Tom Lynch, who has served as interim CEO of MedMen Enterprises since March 2020, was handed the role permanently, the Los Angeles-based marijuana company announced.
“We have an incredible opportunity to capitalize on our recent successes, and continue on our path of rapid growth and profitability,” Lynch said in a news release announcing his full-time role.
Lynch’s annual salary wasn’t disclosed.
But a recent MJBizDaily report on cannabis CEO salaries revealed that former MedMen CEO Ryan Lissack was paid $1.7 million annually in total compensation and co-founder and CEO Adam Bierman received $1.15 million annually in total compensation.
Shares of the embattled company trade as MMEN on the Canadian Securities Exchange and as MMNFF on the U.S. over-the-counter markets.
